The journal of vascular access · 2025
Obesity is an independent risk factor for primary patency loss in 12 months: A 3-year retrospective study of vascular access outcomes.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yoo Young Jin, Heo Seon-Hee
Аннотация
BACKGROUND: Obesity is common among patients with end-stage renal disease; however, its impact on vascular access (VA) outcomes remains uncertain. We aimed to evaluate the association between body mass index (BMI) and VA patency.
METHODS: We retrospectively analyzed 396 patients who underwent arteriovenous fistula (AVF) or arteriovenous graft (AVG) creation (2021-2024), stratifying them by BMI (cutoff of 30 kg/m²). Primary outcomes included primary patency and assisted primary patency, secondary patency, and patient survival.
RESULTS: We analyzed 396 patients (mean age 66.0 ± 14.2 years; 62.1% male). Comorbidities were frequent: hypertension 94.2%, diabetes 54.8%, coronary artery disease 35.6%, peripheral arterial disease 21.7%, cerebrovascular disease 23.0%, and cancer 25.0%. Prior kidney transplantation and renal replacement therapy were present in 12.6% and 69.9% of patients, respectively. Left-sided access and autologous access was predominated (89.9% and 68.2% each), while secondary vascular access at presentation was uncommon (6.6%). The average follow up period was 8.36 ± 9.27 months. Patients with obesity (BMI ⩾30) had significantly lower primary patency than those without obesity (25.0% vs 48.0%, p = 0.024), with comparable assisted patency and long-term outcomes. BMI ⩾30 was an independent predictor of primary patency loss (hazard ratio (HR) 1.707, p = 0.038). AVG formation was a risk factor for assisted patency failure (HR 8.983, p < 0.001).
CONCLUSION: Obesity was associated with early access failure; not with long-term outcomes. Durable VA outcomes can be achieved in patients with obesity through surveillance and timely interventions.
METHODS: We retrospectively analyzed 396 patients who underwent arteriovenous fistula (AVF) or arteriovenous graft (AVG) creation (2021-2024), stratifying them by BMI (cutoff of 30 kg/m²). Primary outcomes included primary patency and assisted primary patency, secondary patency, and patient survival.
RESULTS: We analyzed 396 patients (mean age 66.0 ± 14.2 years; 62.1% male). Comorbidities were frequent: hypertension 94.2%, diabetes 54.8%, coronary artery disease 35.6%, peripheral arterial disease 21.7%, cerebrovascular disease 23.0%, and cancer 25.0%. Prior kidney transplantation and renal replacement therapy were present in 12.6% and 69.9% of patients, respectively. Left-sided access and autologous access was predominated (89.9% and 68.2% each), while secondary vascular access at presentation was uncommon (6.6%). The average follow up period was 8.36 ± 9.27 months. Patients with obesity (BMI ⩾30) had significantly lower primary patency than those without obesity (25.0% vs 48.0%, p = 0.024), with comparable assisted patency and long-term outcomes. BMI ⩾30 was an independent predictor of primary patency loss (hazard ratio (HR) 1.707, p = 0.038). AVG formation was a risk factor for assisted patency failure (HR 8.983, p < 0.001).
CONCLUSION: Obesity was associated with early access failure; not with long-term outcomes. Durable VA outcomes can be achieved in patients with obesity through surveillance and timely interventions.